Recovery after leucine-rich glioma-inactivated 1 antibody encephalitis hampered by fatigue and cognitive deficits

Takeaway

  • Despite good functional outcomes, long-term fatigue and cognitive impairment remain after recovery from leucine-rich glioma-inactivated 1 antibody encephalitis.

Why this matters

    Despite good functional recovery from early immunotherapy, many individuals continue to have poor cognitive function. This is the first in-depth study of specific functional domains and suggest that fatigue and cognitive deficits should be addressed to achieve optimal long-term clinical outcomes after leucine-rich glioma-inactivated 1 antibody encephalitis.